American Academy of Sleep Medicine Unveils New Guidelines for Combining Behavioral Therapy and Medication to Treat Chronic Insomnia

New American Academy of Sleep Medicine guidelines suggest combining CBT-I with medication may benefit some insomnia patients, but therapy remains the top choice.

By: AXL Media

Published: Apr 22, 2026, 4:21 AM EDT

Source: Information for this report was sourced from American Academy of Sleep Medicine

A New Framework for Sleep Disorder Management

The American Academy of Sleep Medicine has released a comprehensive clinical practice guideline in the Journal of Clinical Sleep Medicine, addressing the frequent but previously under-researched practice of combining treatments for chronic insomnia. While past guidelines from 2017 and 2021 established CBT-I and pharmacotherapy as effective standalone options, they did not provide a framework for their simultaneous or sequential use. This latest update, supported by a systematic review and meta-analysis, aims to provide clinicians with an evidence-based roadmap for managing a disorder that affects approximately 10% to 15% of the adult population.

The Primacy of Cognitive Behavioral Therapy

Despite the evaluation of various drug and therapy combinations, the AASM task force reaffirmed that CBT-I remains the most efficacious first-line treatment for chronic insomnia. Dr. Daniel J. Buysse, the guideline’s lead author and a professor at the University of Pittsburgh, noted that behavioral-psychological treatment often produces durable, meaningful improvements without the secondary risks associated with long-term medication use. Consequently, the guideline includes a conditional suggestion against defaulting to combination therapy over CBT-I alone, emphasizing that the addition of drugs should be a targeted decision rather than a standard starting point.

Strategic Use of Pharmacological Add-Ons

For patients already utilizing pharmacological interventions, the new guideline suggests that transitioning to or adding CBT-I is preferable to continuing with medication alone. The analysis indicated that combining these approaches can yield modest benefits in specific sleep metrics, particularly total sleep time, which may not be fully addressed by therapy in isolation. These findings support a shift away from a "one-size-fits-all" mentality, encouraging sleep specialists to consider combination strategies when a patient’s specific sleep goals or clinical presentation requires a more multifaceted intervention.